Monitoring antithyroid therapy.
Sobel
R
R
Glick
S
S
D000380:Agranulocytosis / Q000139:chemically induced* / Q000188:drug therapy*; D013956:Antithyroid Agents / Q000009:adverse effects*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006111:Graves Disease / Q000188:drug therapy; D006801:Humans
D013956:Antithyroid Agents; D016179:Granulocyte Colony-Stimulating Factor